Skip to main content
. 2017 Nov 28;89(22):2245–2253. doi: 10.1212/WNL.0000000000004687

Table 3.

Summary of treatment-emergent adverse events (TEAEs) following abobotulinumtoxinA injections at any cycle (safety population)

graphic file with name NEUROLOGY2017811869TT3.jpg